Literature DB >> 8497341

Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer.

G Sher1, R Salem, M Feinman, S Dodge, C Zouves, V Knutzen.   

Abstract

OBJECTIVE: To evaluate a new method for preventing the life-endangering complications associated with inadvertent menotropin-induced severe ovarian hyperstimulation in patients undergoing in vitro fertilization and embryo transfer (IVF-ET).
METHODS: Seventeen women each underwent a single cycle of controlled ovarian hyperstimulation with menotropins in preparation for IVF-ET. The indications for IVF-ET were tubal occlusion in nine, endometriosis in six, and unexplained infertility in two. The peak plasma estradiol (E2) concentration before hCG administration was greater than 6000 pg/mL and more than 30 ovarian follicles were detected by transvaginal ultrasound. Thus, life-endangering complications associated with severe ovarian hyperstimulation syndrome were highly likely to occur following hCG administration. Rather than cancel the cycle of treatment, menotropin therapy was discontinued and hCG administration was deferred for a number of days until the plasma E2 concentration fell below 3000 pg/mL ("prolonged coasting"), whereupon hCG was administered and egg retrievals and ETs were duly performed.
RESULTS: None of the women developed severe ovarian hyperstimulation syndrome. There were six viable pregnancies (35.2%), which proceeded normally.
CONCLUSION: This study indicates that "prolonged coasting" prevents severe ovarian hyperstimulation syndrome in severely overstimulated women undergoing IVF-ET, without necessitating cycle cancellation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8497341

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

Review 1.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

2.  Prevention of ovarian hyperstimulation syndrome by early aspiration of small follicles in hyper-responsive patients with polycystic ovaries during assisted reproductive treatment cycles.

Authors:  Oluseye A Oyawoye; Bina Chander; Jocelyn Hunter; Ahmed Abdel Gadir
Journal:  MedGenMed       Date:  2005-08-16

3.  Early timed follicular aspiration prevents severe ovarian hyperstimulation syndrome.

Authors:  T Tomazevic; H Meden-Vrtovec
Journal:  J Assist Reprod Genet       Date:  1996-04       Impact factor: 3.412

4.  GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial.

Authors:  Usama M Fouda; Ahmed M Sayed; Hesham S Elshaer; Bahaa Eldin M Hammad; Mona M Shaban; Khaled A Elsetohy; Mohamed A Youssef
Journal:  J Ovarian Res       Date:  2016-05-17       Impact factor: 4.234

5.  The effect of early coasting on blastocyst development and outcome following blastocyst transfer in IVF/ICSI programme.

Authors:  Chandra Kailasam; Heather Griffith; Paul Wilson; Uma Gordon
Journal:  JBRA Assist Reprod       Date:  2018-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.